Reviewing the options for local estrogen treatment of vaginal atrophy

References

• Mac BrideMBRhodesDJShusterLTVulvovaginal atrophyMayo Clin Proc2010851879420042564
   PubMed Web of Science ®Google Scholar
• StikaCSAtrophic vaginitisDermatol Ther201023551452220868405
   PubMed Web of Science ®Google Scholar
• SantoroNKomiJPrevalence and impact of vaginal symptoms among postmenopausal womenJ Sex Med2009682133214219493278
   PubMed Web of Science ®Google Scholar
• NappiREKokot-KierepaMWomen’s voices in the menopause: results from an international survey on vaginal atrophyMaturitas201067323323820828948
   PubMed Web of Science ®Google Scholar
• Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause SocietyMenopause201320988890223985562
   PubMed Web of Science ®Google Scholar
• KrychmanMLVaginal estrogens for the treatment of dyspareuniaJ Sex Med20118366667421091878
   PubMed Web of Science ®Google Scholar
• RobinsonDCardozoLEstrogens and the lower urinary tractNeurourol Urodyn201130575475721661025
   PubMed Web of Science ®Google Scholar
• HillardTThe postmenopausal bladderMenopause Int2010162748020729499
   PubMedGoogle Scholar
• SturdeeDWPanayNInternational Menopause Society Writing GroupRecommendations for the management of postmenopausal vaginal atrophyClimacteric201013650952220883118
   PubMed Web of Science ®Google Scholar
• JaisamrarnUTriratanachatSChaikittisilpaSGrobPPrasauskasVTaechakraichanaNUltra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophyClimacteric201316334735523347400
   PubMed Web of Science ®Google Scholar
• NachtigallLEComparative study: Replens versus local estrogen in menopausal womenFertil Steril19946111781808293835
   PubMed Web of Science ®Google Scholar
• Osphena (ospemifene) [prescribing information]Florham Park, NJShionogi Inc
   Google Scholar
• NappiREKokot-KierepaMVaginal Health: Insights, Views and Attitudes (VIVA) – results from an international surveyClimacteric2012151364422168244
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and GynecologistsWomen’s Health Care Physicians. Hormone Therapy. Sexual DysfunctionObstet Gynecol20041044S85S91
   Web of Science ®Google Scholar
• ScarabinPYOgerEPlu-BureauGEStrogen and THromboEmbolism Risk Study GroupDifferential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskLancet2003362938242843212927428
   PubMed Web of Science ®Google Scholar
• LokkegaardEAndreasenAHJacobsenRKNielsenLHAggerCLidegaardOHormone therapy and risk of myocardial infarction: a national register studyEur Heart J200829212660266818826989
   PubMed Web of Science ®Google Scholar
• CanonicoMPlu-BureauGLoweGDScarabinPYHormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysisBMJ200833676551227123118495631
   PubMed Web of Science ®Google Scholar
• MargolisKLBondsDERodaboughRJEffect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone TrialDiabetologia20044771175118715252707
   PubMed Web of Science ®Google Scholar
• Premarin (conjugated estrogens) vaginal cream [prescribing information]Philadelphia, PAWyeth Pharmaceuticals Inc, part of Pfizer
   Google Scholar
• Estrace (estradiol vaginal cream, USP, 0.01%) [prescribing information]Rockaway, NJWarner Chilcott (US), LLC
   Google Scholar
• BachmannGBouchardCHoppeDEfficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginallyMenopause200916471972719436223
   PubMed Web of Science ®Google Scholar
• Estring (estradiol vaginal ring) [prescribing information]New York, NYPharmacia and Upjohn Company, Division of Pfizer Inc
   Google Scholar
• WeisbergEAytonRDarlingGEndometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tabletClimacteric200581839215804736
   PubMed Web of Science ®Google Scholar
• Femring (estradiol acetate vaginal ring) [prescribing information]Rockaway, NJWarner Chilcott (US), LLC
   Google Scholar
• HenrikssonLStjernquistMBoquistLCedergrenISelinusIA one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital agingAm J Obstet Gynecol1996174185928572039
   PubMed Web of Science ®Google Scholar
• Vagifem (estradiol vaginal tablets) [prescribing information]Princeton, NJNovo Nordisk Inc
   Google Scholar
• BirkhauserMHPanayNArcherDFUpdated practical recommendations for hormone replacement therapy in the peri- and postmenopauseClimacteric200811210812318365854
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)Guidance for industry: labeling guidance for noncontraceptive estrogen drug products for the treatment of vasomotor symptoms and vulvar and vaginal atrophy symptoms – prescribing information for health care providers and patient labeling Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM135336.pdfAccessed November 30, 2011
   Google Scholar
• SimonJNachtigallLGutRLangEArcherDFUtianWEffective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tabletObstet Gynecol200811251053106018978105
   PubMed Web of Science ®Google Scholar
• UlrichLSNaessenTEliaDGoldsteinJAEugster-HausmannMEndometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophyClimacteric201013322823720423243
   PubMed Web of Science ®Google Scholar
• SimonJNachtigallLUlrichLGEugster-HausmannMGutREndometrial safety of ultra-low-dose estradiol vaginal tabletsObstet Gynecol2010116487688320859151
   PubMed Web of Science ®Google Scholar
• BachmannGThe estradiol vaginal ring – a study of existing clinical dataMaturitas199522SupplS21S298775773
   PubMed Web of Science ®Google Scholar
• Eugster-HausmannMWaitzingerJLehnickDMinimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tabletsClimacteric201013321922720423242
   PubMed Web of Science ®Google Scholar
• DorrMBNelsonALMayerPRPlasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitisFertil Steril20109462365236820466363
   PubMed Web of Science ®Google Scholar